Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system

Science

Volumn 343, Issue 6173, 2014, Pages 881-885

  Akey, David L ^a   Brown, W Clay ^a   Dutta, Somnath ^a   Konwerski, Jamie ^a   Jose, Joyce ^b   Jurkiw, Thomas J ^a   DelProposto, James ^a   Ogata, Craig M ^c   Skiniotis, Georgios ^a,d   Kuhn, Richard J ^b,e   Smith, Janet L ^a,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b PURDUE UNIVERSITY   (United States)

^c ARGONNE NATIONAL LABORATORY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; LIPOPROTEIN; LIPOSOME; NANOPARTICLE; NONSTRUCTURAL PROTEIN 1;

CRYSTAL STRUCTURE; DENGUE FEVER; ELECTRON MICROSCOPY; GENOME; IMMUNE SYSTEM; MEMBRANE; MOLECULAR ANALYSIS; NANOTECHNOLOGY; VIRUS;

ARTICLE; CRYSTAL STRUCTURE; DENGUE VIRUS; ELECTRON MICROSCOPY; FLAVIVIRUS; GENOME; IMMUNE SYSTEM; LIPID BILAYER; MEMBRANE; NONHUMAN; PRIORITY JOURNAL;

NILE [UGANDA]; UGANDA;

DENGUE VIRUS GROUP; FLAVIVIRUS; IXODIDA;

EID: 84894277002     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1247749     Document Type: Article

References (26)

1. B. D. Lindenbach, C. M. Rice, Adv. Virus Res. 59, 23-61 (2003).
2. M. S. Suthar, M. S. Diamond, M. Gale Jr., Nat. Rev. Microbiol. 11, 115-128 (2013).
3. D. A. Muller, P. R. Young, Antiviral Res. 98, 192-208 (2013).
4. A. A. Khromykh, P. L. Sedlak, E. G. Westaway, J. Virol. 74, 3253-3263 (2000).
5. B. D. Lindenbach, C. M. Rice, J. Virol. 73, 4611-4621 (1999).
6. E. G. Westaway, J. M. Mackenzie, M. T. Kenney, M. K. Jones, A. A. Khromykh, J. Virol. 71, 6650-6661 (1997).
7. B. D. Lindenbach, C. M. Rice, J. Virol. 71, 9608-9617 (1997).
8. J. M. Mackenzie, M. K. Jones, P. R. Young, Virology 220, 232-240 (1996).
9. S. Youn et al., J. Virol. 86, 7360-7371 (2012).
10. I. Gutsche et al., Proc. Natl. Acad. Sci. U.S.A. 108, 8003-8008 (2011).
11. D. A. Muller et al., J. Gen. Virol. 93, 771-779 (2012).
12. P. Avirutnan et al., J. Immunol. 187, 424-433 (2011).
13. P. Avirutnan et al., J. Exp. Med. 207, 793-806 (2010).
14. K. M. Chung et al., Proc. Natl. Acad. Sci. U.S.A. 103, 19111-19116 (2006).
15. V. D. Krishna, M. Rangappa, V. Satchidanandam, J. Virol. 83, 4766-4777 (2009).
16. P. R. Young, P. A. Hilditch, C. Bletchly, W. Halloran, J. Clin. Microbiol. 38, 1053-1057 (2000).
17. S. Alcon-LePoder et al., Novartis Found. Symp. 277, 233-247, discussion 247-253 (2006).
18. R. Vita et al., Nucleic Acids Res. 38 (suppl. 1), D854-D862 (2010).
19. H. J. Cheng et al., Exp. Biol. Med. 234, 63-73 (2009).
20. A. K. Falconar, Arch. Virol. 142, 897-916 (1997).
21. A. K. Falconar, Clin. Vaccine Immunol. 15, 549-561 (2008).
22. E. A. Henchal, L. S. Henchal, J. J. Schlesinger, J. Gen. Virol. 69, 2101-2107 (1988).
23. I. J. Liu, C. Y. Chiu, Y. C. Chen, H. C. Wu, J. Biol. Chem. 286, 9726-9736 (2011).
24. J. R. Wilson, P. F. de Sessions, M. A. Leon, F. Scholle, J. Virol. 82, 8262-8271 (2008).
25. F. Civril et al., EMBO Rep. 12, 1127-1134 (2011).
26. C. Motz et al., Science 339, 690-693 (2013).